Enoxaparin peak unknown trade name lovenox onset unknown Classification Dose Route time / frequency Low molecular 40 mg once daily 12 hrs For IV meds, compatibility with IV drips and / or solutions N / A Contraindicated in: hypersensitivity, active major bleed, Use cautiously in severe kidney or liver disease, untreated hypertention, recent history of ulcer disease.
Enoxaparin peak unknown trade name lovenox onset unknown Classification Dose Route time / frequency Low molecular 40 mg once daily 12 hrs For IV meds, compatibility with IV drips and / or solutions N / A Contraindicated in: hypersensitivity, active major bleed, Use cautiously in severe kidney or liver disease, untreated hypertention, recent history of ulcer disease.
Copyright:
Attribution Non-Commercial (BY-NC)
Available Formats
Download as DOC, PDF, TXT or read online from Scribd
Enoxaparin peak unknown trade name lovenox onset unknown Classification Dose Route time / frequency Low molecular 40 mg once daily 12 hrs For IV meds, compatibility with IV drips and / or solutions N / A Contraindicated in: hypersensitivity, active major bleed, Use cautiously in severe kidney or liver disease, untreated hypertention, recent history of ulcer disease.
Copyright:
Attribution Non-Commercial (BY-NC)
Available Formats
Download as DOC, PDF, TXT or read online from Scribd
NURS 1566 Clinical Form 3: Clinical Medications Worksheets
(You will need to make additional copies of these forms)
Generic Name Trade Name Classification Dose Route Time/frequency
Enoxaparin Lovenox Low molecular 40 mg SQ Daily weight heparins Peak Onset Duration Normal dosage range Unknown Unknown 12 hrs Medical patients with acute illness--40 mg once daily
Why is your patient getting this medication For IV meds, compatibility with IV drips and/or solutions Prevention of DVT/Pulmonary Embolism N/A
Mechanism of action and indications Nursing Implications (what to focus on)
(Why med ordered) Contraindications/warnings/interactions Potentiates the inhibitory effect of antithrombin on factor Xa . Contraindicated in: Hypersensitivity, active major bleed, Use and thrombin. Indicated for prevention and treatment of DVT cautiously in severe kidney or liver disease, untreated hypertention, and Pulmonary Embolism recent history of ulcer disease. In geriatric pr’s as the elimination time is decreased.
Common side effects
Bleeding, anemia Interactions with other patient drugs, OTC or herbal Lab value alterations caused by medicine medicines (ask patient specifically) Monitor CBC, platelet count, and stools for occult blood periodically Increased risk for bleeding if used with asparin during therapy. If thrombocytopenia occurs, monitor closely. If hematocrit decreases unexpectedly, assess patient for potential bleeding sites Be sure to teach the patient the following about this medication Advise patient to report any symptoms of unusual bleeding or bruising, dizziness, itching, rash, fever, swelling, or difficulty breathing to health care professional immediately Nursing Process- Assessment Assessment Evaluation (Pre-administration assessment) Why would you hold or not give this Check after giving Assess for abnormal bleeding and monitor med? Signs of bleeding and aPTT. Assess for signs of bleeding and If signs of bleeding and hemorrhage hemorrhage and aPTT levels. hemorrhage (bleeding gums; nosebleed; unusual are present. bruising; black, tarry stools; hematuria; fall in hematocrit or blood pressure; guaiac-positive stools); bleeding from surgical site. Notify physician or other health care professional if these occur